Skip to main content

Table 4 Clinical characteristics for the 33 samples that were analyzed with microarrays in our laboratory

From: Genomic meta-analysis of growth factor and integrin pathways in chronic kidney transplant injury

  Banff0 CAN Significance*
Subject Numbers 9 24  
Recipient Age ± SD 49.7 ± 12.9 45.7 ± 13.1 NS^
% Female Recipients 66.7 45.8 NS
% Recipient African American 0 8.33 NS
% Pre-tx Type II Diabetes 25 17.4 NS
% PRA > 20 0 9.5 NS
HLA Mismatch ± SD 2.3 ± 1.3 2.6 ± 3.2 NS
% Deceased Donor 66.7 69.6 NS
Donor Age ± SD 31.4 ± 13.6 41.6 ± 14.7 NS
% Female Donors 33.3 41.6 NS
% Donor African American 0 6.7 NS
% Induction 66.7 87.5 NS
Serum Creatinine ± SD 3.07 ± 1.2 1.78 ± 1.1 0.01
Time to Biopsy (Days) ± SD 691 ± 550 2009 ± 1367 0.0004
% Calcineurin Inhibitors 87.5 75 NS
% Mycophenolic Acid Derivatives 55.6 70.8 NS
% Oral Steroids 44.5 100 0.0005
C4d Positive Staining (%) 0 13 NS
  1. * Significance for all comparisons were determined with paired Students t-test for pair-wise comparisons of data with Standard Deviations and for dichotomous data comparisons by Chi-Square.
  2. SD = standard deviation from the mean.
  3. ^ NS = not significant (p ≥ 0.05).